New-Onset Atrial Fibrillation after Cardiac Surgery: Pathophysiology, Prophylaxis, and Treatment

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 30, Issue 1, 2016, Pages 200-216

  Lomivorotov, Vladimir V ^a   Efremov, Sergey M ^a   Pokushalov, Eugeniy A ^b   Karaskov, Alexander M ^a  

^a MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

^b Arrhythmia Department and Electrophysiology Laboratory   (Russian Federation)

Author keywords

cardiac surgery; complications; postoperative atrial fibrillation; thromboprophylaxis; treatment

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; COLCHICINE; CORTICOSTEROID; DEXAMETHASONE; DIGOXIN; DISOPYRAMIDE; DRONEDARONE; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MAGNESIUM; OMEGA 3 FATTY ACID; QUINIDINE; SOTALOL; CARDIOTONIC AGENT;

ABLATION THERAPY; CARDIOVERSION; CORONARY ARTERY BYPASS GRAFT; EPIDIDYMIS FAT; HEART ATRIUM PACING; HEART RHYTHM; HEART SURGERY; HUMAN; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NEW-ONSET ATRIAL FIBRILLATION; NONHUMAN; OFF PUMP CORONARY SURGERY; PATHOPHYSIOLOGY; PERICARDIOTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); TISSUE PRESERVATION; ADVERSE EFFECTS; ATRIAL FIBRILLATION; POST EXPOSURE PROPHYLAXIS; POSTOPERATIVE COMPLICATIONS; PROCEDURES; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; HUMANS; POST-EXPOSURE PROPHYLAXIS; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84957839930     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2015.08.003     Document Type: Review

References (180)

1. L.B. Mitchell Incidence, timing and outcome of atrial tachyarrhythmias after cardiac surgery J.S. Steinberg, Atrial Fibrillation After Cardiac Surgery 2000 Kluwer Academic Publishers Norwell, MA 37 50
2. S.F. Aranki, D.P. Shaw, D.H. Adams, and et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources Circulation 94 1996 390 397
3. C. Rostagno, C. Blanzola, F. Pinelli, and et al. Atrial fibrillation after isolated coronary surgery Incidence, long term effects and relation with operative technique. Heart Lung Vessel 6 2014 171 179
4. J.P. Mathew, R. Parks, J.S. Savino, and et al. Atrial fibrillation following coronary artery bypass graft surgery: Predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group JAMA 276 1996 300 306
5. J. Auer, T. Weber, R. Berent, and et al. Postoperative atrial fibrillation independently predicts prolongation of hospital stay after cardiac surgery J Cardiovasc Surg (Torino) 46 2005 583 588
6. M. Hravnak, L.A. Hoffman, M.I. Saul, and et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting Am J Crit Care 11 2002 228 238
7. J.S. Steinberg Postoperative atrial fibrillation: A billion-dollar problem J Am Coll Cardiol 43 2004 1001 1003
8. N. Echahidi, P. Pibarot, G. O'Hara, and et al. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 793 801
9. J.P. Mathew, M.L. Fontes, I.C. Tudor, and et al. A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
10. L.L. Creswell, R.B. Schuessler, M. Rosenbloom, and et al. Hazards of post-operative atrial arrhythmias Ann Thorac Surg 56 1993 539 549
11. M. Banach, J. Rysz, J.A. Drozdz, and et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: A preliminary report Circ J 70 2006 438 441
12. S. Helgadottir, M.I. Sigurdsson, I.L. Ingvarsdottir, and et al. Atrial fibrillation following cardiac surgery: Risk analysis and long-term survival J Cardiothorac Surg 7 2012 87
13. M.J. Kolek, J.D. Muehlschlegel, W.S. Bush, and et al. Genetic and clinical risk prediction model for postoperative atrial fibrillation Circ Arrhythm Electrophysiol 8 2015 25 31
14. N. Echahidi, D. Mohty, P. Pibarot, and et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery Circulation 116 2007 I213 I219
15. J. Heeringa, J.A. Kors, A. Hofman, and et al. Cigarette smoking and risk of atrial fibrillation: The Rotterdam Study Am Heart J 156 2008 1163 1169
16. S. Kodama, K. Saito, S. Tanaka, and et al. Alcohol consumption and risk of atrial fibrillation: A meta-analysis J Am Coll Cardiol 57 2011 427 436
17. L. Frost, P. Vestergaard, and L. Mosekilde Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study Arch Intern Med 164 2004 1675 1678
18. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, and et al. Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
19. M. Daccarett, T.J. Badger, N. Akoum, and et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation J Am Coll Cardiol 57 2011 831 838
20. N. Akoum, C. McGann, G. Vergara, and et al. Atrial fibrosis quantified using late gadolinium enhancement MRI is associated with sinus node dysfunction requiring pacemaker implant J Cardiovasc Electrophysiol 23 2012 44 50
21. H. Calkins, K.H. Kuck, R. Cappato, and et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design Europace 14 2012 528 606
22. J.R. Ehrlich, T.J. Cha, L. Zhang, and et al. Cellular electrophysiology of canine pulmonary vein cardiomyocytes: Action potential and ionic current properties J Physiol 551 2003 801 813
23. M. Gherghiceanu, M.E. Hinescu, F. Andrei, and et al. Interstitial Cajal-like cells (ICLC) in myocardial sleeves of human pulmonary veins J Cell Mol Med 12 2008 1777 1781
24. M.D. Levin, M.M. Lu, N.B. Petrenko, and et al. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers J Clin Invest 119 2009 3420 3436
25. J.M. Davidenko, L. Cohen, R.J. Goodrow, and et al. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium Circulation 79 1989 674 686
26. P.S. Chen, L.S. Chen, M.C. Fishbein, and et al. Role of the autonomic nervous system in atrial fibrillation: Pathophysiology and therapy Circ Res 114 2014 1500 1515
27. B. Maesen, J. Nijs, J. Maessen, M. Allessie, and et al. Post-operative atrial fibrillation: A maze of mechanisms Europace 14 2012 159 174
28. A. Anselmi, G. Possati, and M. Gaudino Postoperative inflammatory reaction and atrial fibrillation: Simple correlation or causation? Ann Thorac Surg 88 2009 326 333
29. S. Wan, M.B. Izzat, T.W. Lee, and et al. Avoiding cardiopulmonary bypass in multivessel CABG reduces cytokine response and myocardial injury Ann Thorac Surg 68 1999 52 56
30. S.S. Panesar, T. Athanasiou, S. Nair, and et al. Early outcomes in the elderly: A meta-analysis of 4921 patients undergoing coronary artery bypass grafting - comparison between off-pump and on-pump techniques Heart 92 2006 1808 1816
31. D. Amar, H. Zhang, S. Miodownik, and et al. Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation J Am Coll Cardiol 42 2003 1262 1268
32. G.A. Fleming, K.T. Murray, C. Yu, and et al. Milrinone use is associated with postoperative atrial fibrillation after cardiac surgery Circulation 118 2008 1619 1625
33. R.O. Feneck, K.M. Sherry, P.S. Withington, and et al. Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery J Cardiothorac Vasc Anesth 15 2001 306 315
34. M. Argalious, P. Motta, F. Khandwala, and et al. 'Renal dose' dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery Crit Care Med 33 2005 1327 1332
35. A. Workman Cardiac adrenergic control and atrial fibrillation Naunyn-Schmiedeberg's Arch Pharmacol 381 2010 235 249
36. B. Ramlawi, H. Otu, S. Mieno, and et al. Oxidative stress and atrial fibrillation after cardiac surgery: A case-control study Ann Thorac Surg 84 2007 1166 1173
37. Y.M. Kim, H. Kattach, C. Ratnatunga, and et al. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery J Am Coll Cardiol 51 2008 68 74
38. L. Jideus, P. Blomstrom, L. Nilsson, and et al. Tachyarrhythmias and triggering factors for atrial fibrillation after coronary artery bypass operation Ann Thorac Surg 69 2000 1064 1069
39. N.S. Lok, and C.P. Lau Presentation and management of patients admitted with atrial fibrillation: A review of 291 cases in a regional hospital Int J Cardiol 48 1995 271 278
40. L.D. Hillis, P.K. Smith, J.L. Anderson, and et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 2011 e652 e735
41. J.M. Raiten, K. Ghadimi, J.G. Augoustides, and et al. Atrial fibrillation after cardiac surgery: Clinical update on mechanisms and prophylactic strategies J Cardiothorac Vasc Anesth 29 2015 806 816
42. E. Damuth, and S. Stahmer Arrhythmias P. Roberts, Comprehensive Critical Care: Adult. Mt Prospect, IL, Society of Critical Care Medicine 2012 221 242
43. G. Hindricks, E. Pokushalov, L. Urbna, and et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT Trial Circ Arrhythm Electrophysiol 3 2010 141 147
44. N. Dagres, H. Kottkamp, C. Piorkowski, and et al. Influence of the duration of Holter monitoring on the detection of arrhythmia recurrences after catheter ablation of atrial fibrillation: Implications for patient follow-up Int J Cardiol 139 2010 305 306
45. M. Brignole, P. Vardas, E. Hoffman, and et al. Indications for the use of diagnostic implantable and external ECG loop recorders Europace 11 2009 671 687
46. C. Chen-Scarabelli, T.M. Scarabelli, K.A. Ellenbogen, and et al. Device-detected atrial fibrillation: What to do with asymptomatic patients? J Am Coll Cardiol 65 2015 281 294
47. P.D. Ziegler, J.L. Koehler, and R. Mehra Comparison of continuous versus intermittent monitoring of atrial arrhythmias Heart Rhythm 3 2006 1445 1452
48. V.V. Lomivorotov, S.M. Efremov, E.A. Pokushalov, and et al. Randomized trial of fish oil infusion to prevent atrial fibrillation after cardiac surgery: Data from an implantable continuous cardiac monitor J Cardiothorac Vasc Anesth 28 2014 1278 1284
49. G.H. Almassi, T. Schowalter, A.C. Nicolosi, and et al. Atrial fibrillation after cardiac surgery: A major morbid event? Ann Surg 226 1997 501 511
50. T.O. Stanley, G.B. Mackensen, H.P. Grocott, and et al. Neurological Outcome Research Group; CARE Investigators of the Duke Heart Center. The impact of post-operative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery Anesth Analg 94 2002 290 295
51. J.T. Gutsche, H. Riha, P. Patel, and et al. Major themes for 2013 in cardiothoracic and vascular anaesthesia and intensive care Heart Lung Vessel 6 2014 79 87
52. M.F. El-Chami, P. Kilgo, V. Thourani, and et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft J Am Coll Cardiol 55 2010 370 376
53. D.C. Burgess, M.J. Kilborn, and A.C. Keech Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: A meta-analysis Eur Heart J 27 2006 2846 2857
54. S. Chatterjee, P. Sardar, D. Mukherjee, and et al. Timing and route of amiodarone for prevention of postoperative atrial fibrillation after cardiac surgery: A network regression meta-analysis Pacing Clin Electrophysiol 36 2013 1017 1023
55. W.T. Fang, H.J. Li, H. Zhang, and et al. The role of statin therapy in the prevention of atrial fibrillation: A meta-analysis of randomized controlled trials Br J Clin Pharmaco l74 2012 744 756
56. P. Kolh, S. Windecker, F. Alfonso, and et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur J Cardiothorac Surg 46 2014 517 592
57. S.J. Connolly, I. Cybulsky, A. Lamy, and et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study Am Heart J 145 2003 226 232
58. P.B. Maniar, N. Balcetyte-Harris, J.E. Tamis, and et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in high-risk patients identified by signal-averaged ECG: Lessons of a pilot study Card Electrophysiol Rev 7 2003 158 161
59. S. Acikel, H. Bozbas, B. Gultekin, and et al. Comparison of the efficacy of metoprolol and carvedilol for preventing atrial fibrillation after coronary bypass surgery Int J Cardiol 126 2008 108 113
60. M. Haghjoo, M. Saravi, M.J. Hashemi, and et al. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: Carvedilol versus metoprolol Heart Rhythm 5 2007 1170 1174
61. K. Yasunari, K. Maeda, M. Nakamura, and et al. Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension Am J Med 116 2004 460 465
62. H. Blessberger, J. Kammler, H. Domanovits, and et al. Perioperative beta-blockers for preventing surgery-related mortality and morbidity Cochrane Database Syst Rev 9 2014 CD004476
63. R. Sanjuán, M. Blasco, N. Carbonell, and et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery Ann Thorac Surg 77 2004 838 843
64. N.Z. Kerin, and S. Jacob The efficacy of sotalol in preventing postoperative atrial fibrillation: A meta-analysis Am J Med 124 2011 875.e1-9
65. P. Polster, and J. Broekhuysen The adrenergic antagonism of amiodarone Biochem Pharmacol 25 1976 131 134
66. S.M. Bagshaw, P.D. Galbraith, L.B. Mitchell, and et al. Prophylactic amiodarone for prevention of atrial fibrillation after cardiac surgery: A meta-analysis Ann Thorac Surg 82 2006 1927 1937
67. L.B. Mitchell, D.V. Exner, D.G. Wyse, and et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: A randomized controlled trial JAMA 294 2005 3093 3100
68. E.L. Gillespie, C.M. White, J. Kluger, and et al. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery Pharmacotherapy 26 2006 499 504
69. Y. Beaulieu, A.Y. Denault, P. Couture, and et al. Perioperative intravenous amiodarone does not reduce the burden of atrial fibrillation in patients undergoing cardiac valvular surgery Anesthesiology 112 2010 128 137
70. G.M. Ayers, T.H. Rho, J. Ben-David, and et al. Amiodarone instilled into the canine pericardial sac migrates transmurally to produce electrophysiologic effects and suppress atrial fibrillation J Cardiovasc Electrophysiol 7 1996 713 721
71. X.D. Feng, X.N. Wang, X.N. Yuan, and et al. Effectiveness of biatrial epicardial application of amiodarone-releasing adhesive hydrogel to prevent postoperative atrial fibrillation J Thorac Cardiovasc Surg 148 2014 939 943
72. N. Kromann, and A. Green Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974 Acta Med Scand 208 1980 401 406
73. A. Keys Coronary heart disease, serum cholesterol, and the diet Acta Med Scand 207 1980 153 160
74. D. Mozaffarian, B.M. Psaty, E.B. Rimm, and et al. Fish intake and risk of incident atrial fibrillation Circulation 110 2004 368 373
75. R. Marchioli, F. Barzi, E. Bomba, and et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione Circulation 105 2002 1897 1903
76. L. Calò, L. Bianconi, F. Colivicchi, and et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial J Am Coll Cardiol 45 2005 1723 1728
77. P. Saravanan, B. Bridgewater, A.L. West, and et al. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial Circ Arrhythm Electrophysiol 3 2010 46 53
78. D. Mozaffarian, R. Marchioli, A. Macchia, and et al. Fish oil and postoperative atrial fibrillation: The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial JAMA 308 2012 2001 2011
79. B. Zhang, Y. Zhen, A. Tao, and et al. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated meta-analysis of randomized controlled trials J Cardiol 63 2014 53 59
80. R. Rodrigo, P. Korantzopoulos, M. Cereceda, and et al. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement J Am Coll Cardiol 62 2013 1457 1465
81. G. Patti, M. Chello, D. Candura, and et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 2006 1455 1461
82. O.J. Liakopoulos, E.W. Kuhn, I. Slottosch, and et al. Preoperative statin therapy for patients undergoing cardiac surgery Cochrane Database Syst Rev 4 2012 CD008493
83. P.O. Bonetti, L.O. Lerman, C. Napoli, and et al. Statin effects beyond lipid lowering - are they clinically relevant? Eur Heart J 24 2003 225 248
84. R.U. Pliquett, K.G. Cornish, J.D. Peuler, and et al. Simvastatin normalizes autonomic neural control in experimental heart failure Circulation 112 2005 1763 1770
85. M. Chello, G. Patti, D. Candura, and et al. Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery Crit Care Med 34 2006 660 667
86. D.G. Wright, and D.J. Lefer Statin mediated protection of the ischemic myocardium Vasc Pharmacol 42 2005 265 270
87. M.A. Chaney Corticosteroids and cardiopulmonary bypass: A review of clinical investigations Chest 121 2002 921 931
88. J. Halonen, P. Halonen, O. Järvinen, and et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: A randomized controlled study JAMA 297 2007 1562 1567
89. J.M. Dieleman, A.P. Nierich, P.M. Rosseel, and et al. Intraoperative high-dose dexamethasone for cardiac surgery: A randomized controlled trial JAMA 308 2012 1761 1767
90. D. van Osch, J.M. Dieleman, D. van Dijk, and et al. Dexamethasone for the prevention of postoperative atrial fibrillation Int J Cardiol 182 2015 431 437
91. A.G. Zaman, F. Alamgir, T. Richens, and et al. The role of signal averaged P wave duration and serum magnesium as a combined predictor of atrial fibrillation after elective coronary artery bypass surgery Heart 77 1997 527 531
92. N.N. Henyan, E.L. Gillespie, C.M. White, and et al. Impact of intravenous magnesium on post-cardiothoracic surgery atrial fibrillation and length of hospital stay: A meta-analysis Ann Thorac Surg 80 2005 2402 2406
93. A.A. Alghamdi, O.O. Al-Radi, and D.A. Latter Intravenous magnesium for prevention of atrial fibrillation after coronary artery bypass surgery: A systematic review and meta-analysis J Card Surg 20 2005 293 299
94. R.C. Cook, M.H. Yamashita, M. Kearns, and et al. Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: A meta-analysis Ann Thorac Surg 95 2013 533 541
95. U. Lange, C. Schumann, and K.L. Schmidt Current aspects of colchicine therapy. Classical indications and new therapeutic uses Eur J Med Res 6 2001 150 160
96. B.T. Emmerson The management of gout N Engl J Med 334 1996 445 451
97. M. Imazio, R. Trinchero, A. Brucato, and et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): A multicentre, randomized, double-blind, placebo-controlled trial Eur Heart J 31 2010 2749 2754
98. D.R. Van Wagoner Colchicine for the prevention of postoperative atrial fibrillation: A new indication for a very old drug? Circulation 124 2011 2281 2282
99. M. Imazio, A. Brucato, P. Ferrazzi, and et al. Colchicine reduces postoperative atrial fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy Circulation 124 2011 2290 2295
100. M. Imazio, A. Brucato, P. Ferrazzi, and et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: The COPPS-2 randomized clinical trial JAMA 312 2014 1016 1023
101. D.G. Katritsis, E.A. Pokushalov, A. Romanov, and et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: A randomized clinical trial J Am Coll Cardiol 62 2013 2318 2325
102. S. Oh, E. Choi, Y. Zhang, and et al. Botulinum toxin injection in epicardial autonomic ganglia temporarily suppresses vagally mediated atrial fibrillation Circ Arrhythm Electrophysiol 4 2011 560 565
103. E.A. Pokyshalov, B. Kozlov, A. Romanov, and et al. Botulinum toxin injection in epicardial fat pads can prevent recurrences of atrial fibrillation after cardiac surgery: Results of a randomized pilot study J Am Coll Cardiol 64 2014 628 629
104. D.N. Wijeysundera, W.S. Beattie, V. Rao, and et al. Calcium antagonists reduce cardiovascular complications after cardiac surgery J Am Coll Cardiol 41 2003 1496 1505
105. T.C. Andrews, S.C. Reimold, J.A. Berlin, and et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery A meta-analysis of randomized control trials. Circulation 84 1991 236 244
106. P.J. Podrid Prevention of postoperative atrial fibrillation: What is the best evidence? J Am Coll Cardiol 34 1999 340 342
107. P.R. Kowey, J.E. Taylor, S.J. Rials, and et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventrucular arrhythmia early after coronary artery bypass grafting Am J Cardiol 69 1992 963 965
108. L.B. Mitchell CCS Atrial Fibrillation Guidelines Committee: Canadian Cardiovascular Society atrial fibrillation guidelines 2010: Prevention and treatment of atrial fibrillation following cardiac surgery Can J Cardiol 27 2011 91 97
109. K. Fan, K.L. Lee, C.S. Chiu, and et al. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery Circulation 102 2000 755 760
110. F. Biancari, and M.A. Mahar Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery J Thorac Cardiovasc Surg 139 2010 1158 1161
111. R.M. Jongman, J.G. Zijlstra, W.F. Kok, and et al. Off-pump CABG surgery reduces systemic inflammation compared with on-pump surgery but does not change systemic endothelial responses: A prospective randomized study Shock 42 2014 121 128
112. G.D. Angelini, F.C. Taylor, B.C. Reeves, and et al. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart Against Cardioplegic Arrest Studies (BHACAS 1 and 2): A pooled analysis of two randomized controlled trials Lancet 359 2002 1194 1199
113. G. Palmer, M.A. Herbert, S.L. Prince, and et al. Coronary Artery Revascularization (CARE) registry: An observational study of on-pump and off-pump coronary artery revascularization Ann Thorac Surg 83 2007 986 991
114. C.H. Møller, L. Penninga, J. Wetterslev, and et al. Off-pump versus on-pump coronary artery bypass grafting for ischaemic heart disease Cochrane Database Syst Rev 3 2012 CD007224
115. J.E. Cummings, I. Gill, R. Akhrass, and et al. Preservation of the anterior fat pad paradoxically decreases the incidence of postoperative atrial fibrillation in humans J Am Coll Cardiol 43 2004 994 1000
116. A. Cherniavsky, Y. Kareva, I. Pak, and et al. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders Interact Cardiovasc Thorac Surg 18 2014 727 731
117. C. Blomstrom-Lundqvist, B. Johansson, E. Berglin, and et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: The SWEDish Multicentre Atrial Fibrillation study (SWEDMAF) Eur Heart J 28 2007 2902 2908
118. E. Pokushalov, A. Romanov, G. Corbucci, and et al. Benefit of ablation of first diagnosed paroxysmal atrial fibrillation during coronary artery bypass grafting: A pilot study Eur J Cardiothorac Surg 41 2012 556 560
119. F. Bakhtiary, P. Therapidis, P. Dzemali, and et al. Impact of high thoracic epidural anesthesia on incidence of perioperative atrial fibrillation in off-pump coronary bypass grafting: A prospective randomized study J Thorac Cardiovasc Surg 134 2007 460 464
120. T.M. Hemmerling, C. Minardi, C. Zaouter, and et al. Sevoflurane causes less arrhythmias than desflurane after off-pump coronary artery bypass grafting: A pilot study Ann Card Anaesth 13 2010 116 122
121. W. Bothe, M. Olschewski, F. Beyersdorf, and et al. Glucose-insulin-potassium in cardiac surgery: A meta-analysis Ann Thorac Surg 78 2004 1650 1657
122. A.F. Abacilar, and O.F. Dogan Levosimendan use decreases atrial fibrillation in patients after coronary artery bypass grafting: A pilot study Heart Surg Forum 16 2013 E287 E294
123. C. Chrysostomou, J. Sanchez-de-Toledo, P. Wearden, and et al. Perioperative use of dexmedetomidine is associated with decreased incidence of ventricular and supraventricular tachyarrhythmias after congenital cardiac operations Ann Thorac Surg 92 2011 964 972
124. X.H. Liu, C.Y. Xu, and G.H. Fan Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: A meta-analysis of published randomized controlled trials BMC Cardiovasc Disord 14 2014 52
125. J.D. Klemperer, I.L. Klein, K. Ojamaa, and et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations Ann Thorac Surg 61 1996 1323 1329
126. C.A. Carnes, M.K. Chung, T. Nakayama, and et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation Circulation Res 89 2001 E32 E38
127. G. Nasso, C. Costantini, A. Petralia, and et al. A new extracorporeal vacuum-assisted device to optimize cardiopulmonary bypass Comparison with the conventional system. Interact Cardiovasc Thorac Surg 12 2011 591 595
128. K. Hashemzadeh, M. Dehdilani, and M. Dehdilani Does off-pump coronary artery bypass reduce the prevalence of atrial fibrillation? J Cardiovasc Thorac Res 5 2013 45 49
129. A.H. Olivencia-Yurvati, W.E. Wallace, N. Wallace, and et al. Intraoperative treatment strategy to reduce the incidence of postcardiopulmonary bypass atrial fibrillation Perfusion 17 Suppl 2002 35 39
130. A.K. Alameddine, P. Visintainer, V.K. Alimov, and et al. Blood transfusion and the risk of atrial fibrillation after cardiac surgery J Card Surg 29 2014 593 599
131. D.C. Adams, E.J. Heyer, A.E. Simon, and et al. Incidence of atrial fibrillation after mild or moderate hypothermic cardiopulmonary bypass Crit Care Med 28 2000 309 311
132. A. Hönisch, N. Theuring, B. Ebner, and et al. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition Basic Res Cardiol 105 2010 155 167
133. V.V. Lomivorotov, V.A. Boboshko, S.M. Efremov, and et al. Levosimendan versus an intra-aortic balloon pump in high-risk cardiac patients J Cardiothorac Vasc Anesth 26 2012 596 603
134. T. Liu, G. Li, and G. Xu Levosimendan may prevent postoperative atrial fibrillation through anti-inflammatory and antioxidant modulation J Cardiothorac Vasc Anesth 23 2009 757 758
135. K.K. Cheruku, A. Ghani, F. Ahmad, and et al. Efficacy of nonsteroidal anti-inflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery Prev Cardiol 7 2004 13 18
136. S.J. Horbach, R.D. Lopes, C. da, J.C. Guaragna, and et al. Naproxen as prophylaxis against atrial fibrillation after cardiac surgery: The NAFARM randomized trial Am J Med 124 2011 1036 1042
137. J.K. Lee, G.J. Klein, A.D. Krahn, and et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: A prospective, randomized pilot study Am Heart J 140 2000 871 877
138. R. Soucier, D. Silverman, M. Abordo, and et al. Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: Neither strategy improves outcomes compared to rate control alone (the PIPAF study) Med Sci Monit 9 2003 PI19 PI23
139. C.T. January, L.S. Wann, J.S. Alpert, and et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society Circulation 130 2014 e199 e267
140. G. Frendl, A.C. Sodickson, M.K. Chung, and et al. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures J Thorac Cardiovasc Surg 148 2014 e153 e193
141. R.J. Valentine, S.F. Rosen, J.E. Cigarroa, and et al. The clinical course of new-onset atrial fibrillation after elective aortic operations J Am Coll Surg 193 2001 499 504
142. A. Bobbio, D. Caporale, E. Internullo, and et al. Postoperative outcome of patients undergoing lung resection presenting with new-onset atrial fibrillation managed by amiodarone or diltiazem Eur J Cardiothorac Surg 31 2007 70 74
143. B. Olshansky, L.E. Rosenfeld, A.L. Warner, and et al. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation J Am Coll Cardiol 43 2004 1201 1208
144. I.C. Van Gelder, H.F. Groenveld, H.J. Crijns, and et al. Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med 362 2010 1363 1373
145. J. Sasao, S.D. Tarver, J.D. Kindscher, and et al. In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol Can J Anaesth 48 2001 985 989
146. A. Sakamoto, M. Kitakaze, S. Takamoto, and et al. Landiolol, an ultra-short-acting β1-blocker, more effectively terminates atrial fibrillation than diltiazem after open heart surgery: Prospective, multicenter, randomized, open-label study (JL-KNIGHT study) Circ J 76 2012 1097 1101
147. A.N. Mooss, R.L. Wurdeman, S.M. Mohiuddin, and et al. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery Am Heart J 140 2000 176 180
148. J.E. Tisdale, I.D. Padhi, A.D. Goldberg, and et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery Am Heart J 135 1998 739 747
149. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
150. C.B. de Vos, R. Pisters, R. Nieuwlaat, and et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis J Am Coll Cardiol 55 2010 725 731
151. O.D. Pedersen, H. Bagger, N. Keller, and et al. Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: A Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy Circulation 104 2001 292 296
152. C. Torp-Pedersen, M. Møller, P.E. Bloch-Thomsen, and et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group N Engl J Med 341 1999 857 865
153. H. Oral, J.J. Souza, G.F. Michaud, and et al. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment N Engl J Med 340 1999 1849 1854
154. D.S. Echt, P.R. Liebson, L.B. Mitchell, and et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
155. B.N. Singh, S.N. Singh, D.J. Reda, and et al. Amiodarone versus sotalol for atrial fibrillation N Engl J Med 352 2005 1861 1872
156. J.P. Piccini, V. Hasselblad, E.D. Peterson, and et al. Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation J Am Coll Cardiol 54 2009 1089 1095
157. AFFIRM First Antiarrhythmic Drug Substudy Investigators: Maintenance of sinus rhythm in patients with atrial fibrillation: An AFFIRM substudy of the first antiarrhythmic drug J Am Coll Cardiol 42 2003 20 29
158. N. Freemantle, C. Lafuente-Lafuente, S. Mitchell, and et al. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation Europace 13 2011 329 345
159. L. Køber, C. Torp-Pedersen, J.J. McMurray, and et al. Increased mortality after dronedarone therapy for severe heart failure N Engl J Med 358 2008 2678 2687
160. S.J. Connolly, A.J. Camm, J.L. Halperin, and et al. Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 365 2011 2268 2276
161. T. Komatsu, H. Tachibana, Y. Satoh, and et al. Prospective comparative study of intravenous cibenzoline and disopyramide therapy in the treatment of paroxysmal atrial fibrillation after cardiovascular surgery Circ J 74 2010 1859 1865
162. M.V. Sherrid, I. Barac, W.J. McKenna, and et al. Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 45 2005 1251 1258
163. M. Hamada, S. Ikeda, and Y. Shigematsu Advances in medical treatment of hypertrophic cardiomyopathy J Cardiol 64 2014 1 10
164. C. Lafuente-Lafuente, S. Mouly, M.A. Longás-Tejero, and et al. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials Arch Intern Med 166 2006 719 728
165. T.V. Glotzer, E.G. Daoud, D.G. Wyse, and et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: The TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
166. P.D. Ziegler, T.V. Glotzer, E.G. Daoud, and et al. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention Am J Cardiol 110 2012 1309 1314
167. B.F. Gage, A.D. Waterman, W. Shannon, and et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
168. G.Y. Lip, R. Nieuwlaat, R. Pisters, and et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The Euro Heart Survey on Atrial Fibrillation Chest 137 2010 263 272
169. R. Pisters, D.A. Lane, R. Nieuwlaat, and et al. A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey Chest 138 2010 1093 1100
170. M.C. Fang, A.S. Go, Y. Chang, and et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study J Am Coll Cardiol 58 2011 395 401
171. B.F. Gage, Y. Yan, P.E. Milligan, and et al. Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF) Am Heart J 151 2006 713 719
172. B.F. Gage, W.C. van, L. Pearce, and et al. Selecting patients with atrial fibrillation for anticoagulation: Stroke risk stratification in patients taking aspirin Circulation 110 2004 2287 2292
173. A.L. Klein, R.A. Grimm, R.D. Murray, and et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation N Engl J Med 344 2001 1411 1420
174. W.J. Manning, D.I. Silverman, C.S. Keighley, and et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study J Am Coll Cardiol 25 1995 1354 1361
175. W.A. Jaber, D.L. Prior, M. Thamilarasan, and et al. Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: A transesophageal echocardiographic study Am Heart J 140 2000 150 156
176. F. Van de Werf, M. Brueckmann, S.J. Connolly, and et al. A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN) Am Heart J 163 2012 931 937
177. J.W. Eikelboom, S.J. Connolly, M. Brueckmann, and et al. Dabigatran versus warfarin in patients with mechanical heart valves N Engl J Med 369 2013 1206 1214
178. V.Y. Reddy, S.K. Doshi, H. Siever, and et al. Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients with Atrial Fibrillation: 2.3 Year Follow-Up of the PROTECT AF Trial (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial Circulation 127 2013 720 729
179. V.Y. Reddy, S. Mobius-Winkler, M.A. Miller, and et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: The ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol 61 2013 2551 2556
180. D.R. Holmes Jr, S. Kar, M.J. Price, and et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial J Am Coll Cardiol 64 2014 1 12